Together, our findings demonstrate that LLC tumor tissues exhibit cell type-specific transcriptional regulatory all cellular compartments, with particular biological significance emerging from the endothelial compartment where the angiogenesis-modulating capacity of Meox1 positions it as a novel therapeutic target warranting mechanistic dissection of vascular niche reprogramming. This evidence concerns the gene MEOX1 and neoplasm.